Zions Bancorporation, National Association’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$25.9K Sell
384
-143
-27% -$9.53K ﹤0.01% 711
2026
Q1
$33.1K Sell
527
-1,791
-77% -$125K ﹤0.01% 620
2025
Q4
$154K Buy
2,318
+2,103
+978% +$136K 0.01% 468
2025
Q3
$14.5K Sell
215
-323
-60% -$25.6K ﹤0.01% 648
2025
Q2
$47K Buy
538
+147
+38% +$11.5K ﹤0.01% 532
2025
Q1
$26.7K Buy
+391
New +$31.9K ﹤0.01% 604

Other funds holding DXCM

Zions Bancorporation, National Association's DXCM Position: Q2 2026 in Review

Zions Bancorporation, National Association reduced its DexCom (DXCM) stake by 27% in Q2 2026, selling an estimated $9.53K and leaving 384 shares worth $25.9K. The position accounts for ﹤0.01% of the portfolio, ranked #711.

Zions Bancorporation, National Association first reported a position in DXCM in Q1 2025 and has held it in 6 quarters since. The position peaked at $154K in Q4 2025. 353 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Zions Bancorporation, National Association held 384 shares of DexCom worth $25.9K as of Q2 2026.
  • Zions Bancorporation, National Association sold 143 DexCom shares in Q2 2026, an estimated $9.53K.
  • DexCom made up ﹤0.01% of Zions Bancorporation, National Association's portfolio in Q2 2026, its #711 holding.
  • Zions Bancorporation, National Association first reported a position in DexCom in Q1 2025 and has held it in 6 quarters since.
  • Zions Bancorporation, National Association's DexCom position peaked at $154K in Q4 2025.
  • 353 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Zions Bancorporation, National Association's 13F filing for Q2 2026, filed 31 Jul 2026.